Q4 2024 Results Conference Call March 12, 2025 5:30 PM ETCompany ParticipantsDan Goldberger - CEO & DirectorJoshua Lev ...

"In multiple clinical trials, CEFALY's neuromodulation device has been proven to help patients reduce the frequency of migraine attacks and relieve debilitating symptoms without medication," said ...

After hours: March 11 at 4:20:00 PM EDT Loading Chart for ECOR ...

Our goal is to connect healthcare professionals, investors, and the medical device industry by offering breaking news and articles authored by experts in this space. This content aims to stimulate ...

A Missouri woman has been charged in connection to the death of her toddler after police said the child was not fed for almost two days. The Missouri State Highway Patrol said in a press release ...

ECOR stock opened at $14.10 on Monday. electroCore has a twelve month low of $5.32 and a twelve month high of $19.49. The company has a market cap of $93.85 million, a P/E ratio of -7.70 and a ...

Blurry vision and headaches often occur together with migraine or cluster headaches, or these symptoms may indicate eye strain. Additionally, blurry vision combined with a headache can sometimes ...

The money will support an ongoing pivotal trial of 4C Medical Technologies' transcatheter mitral valve replacement device in the U.S. and Europe.

Electronic devices are components for controlling the flow of electrical currents for the purpose of information processing and system control. Prominent examples include transistors and diodes ...